Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer

Surgery

Volumn 134, Issue 6, 2003, Pages 946-954

  Kouvaraki, Maria A ^a   Shapiro, Suzanne E ^a   Fornage, Bruno D ^a   Edeiken Monro, Beth S ^a   Sherman, Steven I ^a   Vassilopoulou Sellin, Rena ^a   Lee, Jeffrey E ^a   Evans, Douglas B ^a   Heller, Keith S ^b   Siperstein, Allan ^b   Hay, Ian D ^b   Rosen, Irving B ^b   Wilhelm, Scott ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Univ TX M D Anderson Cancer Ctr ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; CANCER LOCALIZATION; CHILD; CONFERENCE PAPER; DIAGNOSTIC VALUE; ECHOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT CANCER; THYROID FOLLICULAR CARCINOMA; THYROID MEDULLARY CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY;

EID: 10744223753     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6060(03)00424-0     Document Type: Conference Paper

References (25)

1. Tubiana M, Schlumberger M, Rougier P, Laplanche A, Benhamou E, Gardet P, et al. Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 1985;55:794-804.
2. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin 2003;53:5-26.
3. Samaan NA, Maheshwari YK, Nader S, Hill CS Jr, Schultz PN, Haynie TP, et al. Impact of therapy for differentiated carcinoma of the thyroid: an analysis of 706 cases. J Clin Endocrinol Metab 1983;56:1131-8.
4. Mazzaferri EL, Kloos RT. Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 2001;86:1447-63.
5. Hay ID, Thompson GB, Grant CS, Bergstralh EJ, Dvorak CE, Gorman CA, et al. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg 2002;26:879-85.
6. Simon D, Goretzki PE, Witte J, Roher HD. Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma. World J Surg 1996;20:860-6; discussion 6.
7. Kallinowski F, Buhr HJ, Meybier H, Eberhardt M, Herfarth C. Medullary carcinoma of the thyroid - therapeutic strategy derived from fifteen years of experience. Surgery 1993; 114:491-6.
8. Sherman SI, Ball DW, Beenken SW, Byrd D, Clark OH, Daniels GH, et al. NCCN Oncology Practice Guidelines v.1.2003. National Comprehensive Cancer Network. Available at: http://www.nccn.org/physician_gls/f_guidelines. html. Accessed 4-28-2003
9. Simeone JF, Daniels GH, Hall DA, McCarthy K, Kopans DB, Butch RJ, et al. Sonography in the follow-up of 100 patients with thyroid carcinoma. AJR Am J Roentgenol 1987;148: 45-9.
10. Antonelli A, Miccoli P, Ferdeghini M, Di Coscio G, Alberti B, Iacconi P, et al. Role of neck ultrasonography in the follow-up of patients operated on for thyroid cancer. Thyroid 1995;5:25-8.
11. Franceschi M, Kusic Z, Franceschi D, Lukinac L, Roncevic S. Thyroglobulin determination, neck ultrasonography and iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma. J Nucl Med 1996;37:446-51.
12. Sherman SI. Thyroid carcinoma. Lancet 2003;361:501-11.
13. Esnaola NF, Cantor SB, Sherman SI, Lee JE, Evans DB. Optimal treatment strategy in patients with papillary thyroid cancer: a decision analysis. Surgery 2001;130:921-30.
14. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, et al. AJCC cancer staging manual. 6th ed. New York: Springer-Verlag; 2002.
15. Fleming JB, Lee JE, Bouvet M, Schultz PN, Sherman SI, Sellin RV, et al. Surgical strategy for the treatment of medullary thyroid carcinoma. Ann Surg 1999;230:697-707.
16. Ahuja AT, Chow L, Chick W, King W, Metreweli C. Metastatic cervical nodes in papillary carcinoma of the thyroid: ultrasound and histological correlation. Clin Radiol 1995;50:229-31.
17. Cholewinski SP, Yoo KS, Klieger PS, O'Mara RE. Absence of thyroid stunning after diagnostic whole-body scanning with 185 MBq 1311. J Nucl Med 2000;41:1198-202.
18. Fratkin MJ, Newsome HH Jr, Sharpe AR Jr, Tatum JL. Cervical distribution of iodine 131 following total thyroid-ectomy for thyroid cancer. Arch Surg 1983;118:864-7.
19. Hodgson DC, Brierley JD, Tsang RW, Panzarella T. Prescribing 131 Iodine based on neck uptake produces effective thyroid ablation and reduced hospital stay. Radiother Oncol 1998;47:325-30.
20. Baatenburg de Jong RJ, Rongen RJ, Lameris JS, Harthoorn M, Verwoerd CD, Knegt P. Metastatic neck disease. Palpation vs ultrasound examination. Arch Otolaryngol Head Neck Surg 1989;115:689-90.
21. Bruneton JN, Roux P, Caramella E, Demard F, Vallicioni J, Chauvel P. Ear, nose, and throat cancer: ultrasound diagnosis of metastasis to cervical lymph nodes. Radiology 1984;152:771-3.
22. Gorges R, Eising EG, Fotescu D, Renzing-Kohler K, Frilling A, Schmid KW, et al. Diagnostic value of high-resolution B-mode and power-mode sonography in the follow-up of thyroid cancer. Eur J Ultrasound 2003;16:191-206.
23. Na DG, Lim HK, Byun HS, Kim HD, Ko YH, Baek JH. Differential diagnosis of cervical lymphadenopathy: usefulness of color Doppler sonography. AJR Am J Roentgenol 1997;168:1311-6.
24. Frasoldati A, Pesenti M, Gallo M, Caroggio A, Salvo D, Valcavi R. Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma. Cancer 2003;97:90-6.
25. Hay ID, McConahey WM, Goellner JR. Managing patients with papillary thyroid carcinoma: insights gained from the Mayo Clinic's experience of treating 2,512 consecutive patients during 1940 through 2000. Trans Am Clin Climatol Assoc 2002;113:241-60.